Electrical and Behavioral Signals in OCD Could Guide Adaptive Therapy
Researchers hope that an adaptive DBS that can adjust stimulation intensity in response to symptoms may provide more relief and fewer side effects for patients.
Stay updated with breaking news from Intelligent Systems Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers hope that an adaptive DBS that can adjust stimulation intensity in response to symptoms may provide more relief and fewer side effects for patients.
By SUSAN JONES The search committee for the new dean of the School of Computing and Information is wrapping up the first phase of its process after holding four forums last week to get input from faculty, staff, students and the University community. Paul Cohen, SCI founding dean, stepped down from that role and returned to the faculty in July 2020. Bruce Childers, senior
Published: Dec 23, 2020 MALVERN, Pa., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Ocugen, Inc., (NASDAQ: OCGN), a leading biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies, today announced the appointment of a vaccine scientific advisory board comprised of leading academic and industry experts in the vaccine field to evaluate the clinical and regulatory path to approval in the US market of Bharat Biotech’s COVAXIN™, a whole-virion inactivated COVID-19 vaccine candidate to be co-developed by Ocugen and Bharat Biotech for the US m...